Table 1. Effects of systemically administered ageing and rejuvenation factors on healthy brains.
Factors | Organism or model | Effect on the brain | References |
---|---|---|---|
Blood or plasma from old mouse | Young adult mouse | In the young brain: reduction in neurogenesis; increase in microglial reactivity; reduction in learning and memory. | 50 |
CCL11 | Young adult mouse | In the young brain: reduction in neurogenesis; increase in microglial reactivity; reduction in learning and memory. | 50 |
B2M | Young adult mouse | In the young brain: reduction in neurogenesis; increase in microglial reactivity; reduction in learning and memory. | 54 |
Blood or plasma from young mouse | Aged mouse | Increase in neurogenesis; reduction in microglial reactivity; improvement in learning and memory; improvement in olfactory discrimination. | 80, 81 |
IGF1 | Young adult rat | Increase in neurogenesis. | 91 |
IGF2 | Young adult mouse | Increase in retention and persistence of working, short-term and long-term memory. | 92 |
GHRH | Healthy older people; people with mild cognitive impairment | A 20-week treatment improved executive functions in both groups of people. | 94 |
GnRH | Aged mouse | Increase in neurogenesis; improvement in memory. | 95 |
GDF-11 | Aged mouse | Increase in neurogenesis; increase in cerebrovascular integrity. | 81 |
Abbr: IGF, insulin-like growth factor; GHRH, growth hormone-releasing hormone; GnRH, gonadotropin-releasing hormone; GDF-11, growth and differentiation factor 11.